Page 21 - Mobile Android News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Adding quizartinib to standard chemotherapy and up to 3 years of continuation therapy extended OS among a subset of older adults with newly diagnosed acute myeloid leukemia, according to results of the phase 3 QuANTUM-First trial.The findings, presented during the European Hematology Association Hybrid 2022 Congress, additionally showed quizartinib (Daiichi Sankyo) had a favorable safety profile,

Ocular Surgery News | In the era of digital communication and social media, establishing and protecting the reputation of a medical practice have become even more critical.In the past, reputation was built on face-to-face interaction, personal recommendation and word-of-mouth referral among friends, family members and colleagues. Marketing statistics said that, on average, happy customers would share their experiences

Blogs | | Many of us doctors would prefer not to think about online patient reviews. That’s natural because those who post negative reviews have little accountability for their words, and privacy laws make us almost powerless to respond.

Sesame-induced anaphylaxis, usually due to hummus ingestion, common represented the first manifestation of sesame allergy among children in Canada, according to a study published in Annals of Allergy, Asthma & Immunology. Also, epinephrine tended to be underutilized in these cases at home, by emergency medical services and in the ED, the researchers wrote.

CHICAGO — The FDA and Health Canada have approved Johnson & Johnson Vision’s Acuvue Oasys Max 1-Day and 1-Day Multifocal, and CE mark activities are complete, the company announced at Optometry’s Meeting. The contact lenses were developed to provide all day comfort and visual clarity, in response to feedback from eye care professionals and patients that long days and